Shinva Medical Instrument Co Ltd
SSE:600587
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Shinva Medical Instrument Co Ltd
SSE:600587
|
CN |
|
S
|
Sai Gon Thuong Tin Real Estate JSC
VN:SCR
|
VN |
|
Chobi Co Ltd
KRX:001550
|
KR |
|
Nam.R SA
PAR:ALNMR
|
FR |
|
O
|
Oishi Group PCL
SET:OISHI
|
TH |
|
Dream Industrial Real Estate Investment Trust
TSX:DIR.UN
|
CA |
|
MRV Engenharia e Participacoes SA
BOVESPA:MRVE3
|
BR |
|
Ninestar Corp
SZSE:002180
|
CN |
|
Match Group Inc
NASDAQ:MTCH
|
US |
|
Gujarat Raffia Industries Ltd
NSE:GUJRAFFIA
|
IN |
|
P
|
Pantoro Ltd
ASX:PNR
|
AU |
|
Crocs Inc
NASDAQ:CROX
|
US |
|
A
|
Apotea AB (publ)
STO:APOTEA
|
SE |
|
Pavlovskiy Avtobus PAO
MOEX:PAZA
|
RU |
|
W
|
Wisdom Sports Group
HKEX:1661
|
CN |
|
Ufuk Yatirim Yonetim ve Gayrimenkul AS
IST:UFUK.E
|
TR |
|
Hyliion Holdings Corp
NYSE:HYLN
|
US |
|
E
|
Empyrean Technology Co Ltd
SZSE:301269
|
CN |
|
P
|
Platzer Fastigheter Holding AB (publ)
STO:PLAZ B
|
SE |
Discount Rate
Cost of Equity
Discount Rate
Shinva Medical Instrument Co Ltd's Cost of Equity, calculated using the formula
Risk-Free Rate + Beta x ERP,
stands at 5.51%.
The Beta, indicating the stock's volatility relative to the market, is 0.88, while the current Risk-Free Rate, based on government bond yields, is 1.83%, and the ERP, measuring the extra return over the risk-free rate required by investors, is 4.18%.
WACC
Discount Rate
Shinva Medical Instrument Co Ltd's Weighted Average Cost of Capital (WACC) is calculated as the weighted average of its cost of equity and cost of debt, adjusted for tax.
The WACC stands at 5.49%. This includes the cost of equity at 5.51%, calculated as Risk-Free Rate + Beta x ERP, and the cost of debt at 5.3%, reflecting the interest rate on
Shinva Medical Instrument Co Ltd's debt adjusted for tax benefits. The weight of debt in the capital structure is 10.9%.
What is Shinva Medical Instrument Co Ltd's discount rate?
Shinva Medical Instrument Co Ltd
's current Cost of Equity is 5.51%, while its WACC stands at 5.49%.
The selection of the appropriate discount rate is contingent on the type of cash flows being discounted.
For Equity Valuation: When valuing equity, especially in scenarios where you are discounting cash flows to equity holders (such as Net Income, Earnings Per Share (EPS), or Free Cash Flow to Equity), the Cost of Equity should be used.
For Firm Valuation: In contrast, when valuing the entire firm and discounting cash flows available to both debt and equity holders (like Free Cash Flow to the Firm), the Weighted Average Cost of Capital (WACC) is the appropriate rate."
How is Cost of Equity for Shinva Medical Instrument Co Ltd calculated?
The Cost of Equity represents the return a company must offer investors to compensate for the risk of investing in its stock. It's calculated using the Capital Asset Pricing Model (CAPM), which combines the risk-free rate, the stock's beta, and the equity risk premium (ERP).
This model considers the inherent risk of investing in the stock compared to a risk-free investment and the market's overall risk.
Here is how we calculate the cost of equity for
Shinva Medical Instrument Co Ltd
How is WACC for Shinva Medical Instrument Co Ltd calculated?
WACC, or Weighted Average Cost of Capital, is a calculation that reflects the average rate of return a company is expected to pay its security holders to finance its assets. It is a critical measure in financial analysis for valuing a company’s entire operations.
The WACC formula combines the costs of equity and debt, weighted by their respective proportions in the company's capital structure.
Here is how we calculate WACC for
Shinva Medical Instrument Co Ltd
